Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2900
-0.0038 (-1.29%)
At close: Aug 13, 2025, 4:00 PM
0.2820
-0.0080 (-2.76%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.65 million as of August 14, 2025. Its market cap has decreased by -78.36% in one year.
Market Cap
13.65M
Enterprise Value
11.56M
1-Year Change
-78.36%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.65M, a decrease of -79.33%. That is a compound annual growth rate of -52.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 13.65M | -48.67% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |